Dengue virus (DENV) has become a global health threat with about half of the world's
population at risk of infection. Although the disease caused by DENV is self-limiting in the …

Oral drug delivery is the preferred route of drug administration for patients, especially those
who need long-term medication. Recently, bioinspired drug delivery systems have emerged …

Introduction: Dengue virus is a global health threat, with approximately 390 million dengue
infections annually. Efficient vaccines for dengue prevention are currently lacking. This …

Dengue virus (DENV) is a global health threat causing about half of the worldwide
population to be at risk of infection, especially the people living in tropical and subtropical …

Vaccines that are delivered orally have several advantages over their counterparts that are
administered via injection. Despite the advantages of oral delivery, however, approved oral …

The rapid spread of the COVID-19 pandemic, with its devastating medical and economic
impacts, triggered an unprecedented race toward development of effective vaccines. The …

Background Escherichia coli heat labile toxin B subunit (LTB) is one of the most popular oral
vaccine adjuvants and intestine adsorption enhancers. It is often expressed as a fusion …

Yeasts are considered a useful system for the development of vaccines for human and
veterinary health. Species such as Saccharomyces cerevisiae and Pichia pastoris have …

In the last decades, technological advances for RNA manipulation enabled and expanded
its application in vaccine development. This approach comprises synthetic single-stranded …

Dengue, caused by the dengue virus (DENV), affects millions of people worldwide every
year. This virus has two distinct life cycles, one in the human and another in the mosquito …